Respiratory synctial virus (RSV), a common etiologic agent of epidemic pediatric wheezing, produces pulmonary inflammation by induces the transcriptional production of the CC chemokine, RANTES, by the airway epithelium. Although the nuclear factor of kappaB (NF-kappaB) response element is necessary for RANTES expression, two additional cis DNA control elements have been identified preliminary in its proximal promoter. In a eukaryotic cell expression assay, we demonstrate that selective expression of the RSV F glycoprotein activates RANTES promoter expression. In addition, RSV infection activates mitogen activated protein kinase (MAPK) kinase (MEK), a signaling molecule required for inducible RANTES secretion. In this project, we will pursue the hypothesis that RSV activates RANTES transcription through two separate cis DNA control elements. RSV activates RANTES secretion through expression of the F glycoprotein and activation of the MAPK cascade.
Our specific aims are to: 1) To define the mechanism for transcriptional activation of RANTES by RSV. The cis elements required for RANTES induction by RSV (Domains 1 and 2) will be defined functionally by transient transfection assays and regions of protein-DNA interaction will be identified by DNase I footprint analysis; 2) To determine the mechanism for RSV glycoprotein F in expression, we will identify the necessary domains necessary for RANTES production, and establish the relationship of F to MAPK activation; 3) To determine the mechanism of NF-kappaB activation of RANTES by RSV. RANTES is distinct from other NF-kappaB responsive genes in that RANTES is non- inducible without ankyrin repeat protect expression (such as IkappaBR). We have discovered the expression the an additional ankyrin repeat containing protein, BCL-3, not subunits binding to the RANTES and, separately, the highly inducible IL-8 gene promoter to the hypothesis that ankyrin repeat containing proteins are recruited to the RANTES NF- kappaB complex. These studies will identify control mechanisms required for RANTES induction in pulmonary infection and may allow for identification of targets that can be use to block eosinophil inflammation in viral-exacerbated asthma.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI046004-01
Application #
6225486
Study Section
Special Emphasis Panel (ZAI1-PTM-I (M1))
Project Start
1999-09-01
Project End
2003-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Welliver, Timothy P; Reed, Jennifer L; Welliver Sr, Robert C (2008) Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases. Pediatr Infect Dis J 27:S92-6
Garofalo, Roberto P; Hintz, Karen H; Hill, Vanessa et al. (2005) A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus. J Med Virol 75:282-9
Bacsi, Attila; Dharajiya, Nilesh; Choudhury, Barun K et al. (2005) Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis. J Allergy Clin Immunol 116:836-43
Boldogh, Istvan; Bacsi, Attila; Choudhury, Barun K et al. (2005) ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation. J Clin Invest 115:2169-79
Garofalo, Roberto P; Hintz, Karen H; Hill, Vanessa et al. (2004) Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J Med Virol 73:289-94
Haeberle, Helene A; Casola, Antonella; Gatalica, Zoran et al. (2004) IkappaB kinase is a critical regulator of chemokine expression and lung inflammation in respiratory syncytial virus infection. J Virol 78:2232-41
Gorska, Magdalena M; Stafford, Susan J; Cen, Osman et al. (2004) Unc119, a novel activator of Lck/Fyn, is essential for T cell activation. J Exp Med 199:369-79
Cen, Osman; Gorska, Magdalena M; Stafford, Susan J et al. (2003) Identification of UNC119 as a novel activator of SRC-type tyrosine kinases. J Biol Chem 278:8837-45
Adachi, Tetsuya; Stafford, Susan; Kayaba, Hiroyuki et al. (2003) Myosin light chain kinase mediates eosinophil chemotaxis in a mitogen-activated protein kinase-dependent manner. J Allergy Clin Immunol 111:113-6
Leonard, Patricia; Sur, Sanjiv (2003) Interleukin-12: potential role in asthma therapy. BioDrugs 17:1-7

Showing the most recent 10 out of 20 publications